Cost effectiveness analysis in health care: contraindications

被引：68
作者：
Donaldson, C [1 ]
Currie, G
Mitton, C
机构：
[1] Univ Newcastle Upon Tyne, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Business, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB 52N 4N1, Canada
[4] Univ Calgary, Dept Econ, Calgary, AB 52N 4N1, Canada
[5] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB T2N 1N4, Canada
来源：
BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7369期
关键词：
D O I：
10.1136/bmj.325.7369.891
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In economic evaluation of healthcare interventions, the dominant practice is to calculate an incremental cost effectiveness ratio, usually based on the comparison of a new intervention against current practice. Canadian and UK health economists question the economic foundations of such an approach.
引用
收藏
页码：891 / 894
页数：4
相关论文
共 25 条
  • [1] Donaldson C, 1996, HEALTH ECON, V5, P267, DOI 10.1002/(SICI)1099-1050(199605)5:3<267::AID-HEC209>3.0.CO
  • [2] 2-X
  • [3] Guidelines for authors and peer reviewers of economic submissions to the BMJ
    Drummond, MF
    Jefferson, TO
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7052) : 275 - 283
  • [4] Screening for hereditary hemochromatosis in siblings and children of affected patients - A cost-effectiveness analysis
    El-Serag, HB
    Inadomi, JM
    Kowdley, KV
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (04) : 261 - +
  • [5] The cost effectiveness of combination antiretroviral therapy for HIV disease.
    Freedberg, KA
    Losina, E
    Weinstein, MC
    Paltiel, AD
    Cohen, CJ
    Seage, GR
    Craven, DE
    Zhang, H
    Kimmel, AD
    Goldie, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 824 - 831
  • [6] GAFNI A, 1993, CAN MED ASSOC J, V148, P913
  • [7] Twenty years of health care economic analysis in Spain:: Are we doing well?
    García-Altés, A
    [J]. HEALTH ECONOMICS, 2001, 10 (08) : 715 - 729
  • [8] GOLD MR, 2001, PHARMACOECONOMICS, V19, P609
  • [9] Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis
    Gould, MK
    Dembitzer, AD
    Sanders, GD
    Garber, AM
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (10) : 789 - +
  • [10] The influence of economic evaluation studies on decision making. A European survey
    Hoffmann, C
    von der Schulenburg, JMG
    [J]. HEALTH POLICY, 2000, 52 (03) : 179 - 192
123